Paul Quinlan
Overview
Paul Quinlan received an average of $2M in total compensation, including $395K in salary, at Cymabay Therapeutics from 2018 to 2022.
Source: SEC filings on April 19, 2023 and April 26, 2019.
Related executives
We found nine more executives who work or worked at Cymabay Therapeutics.
Sujal Shah
Cymabay Therapeutics
Chief Executive Officer
Charles McWherter
Cymabay Therapeutics
President of R&D
Dennis Kim
Cymabay Therapeutics
Chief Medical Officer
Lewis Stuart
Cymabay Therapeutics
Chief Commercial Officer
Janet Dorling
Cymabay Therapeutics
Former Chief Commercial Officer
Pol Boudes
Cymabay Therapeutics
Chief Medical Officer
Klara Dickinson
Cymabay Therapeutics
Chief Regulatory and Compliance Officer
Daniel Menold
Cymabay Therapeutics